March 10, 2026

Triangle Insights Group by Valeris Announces Appointment of Erin Solano to Partner

DURHAM, NC— Triangle Insights Group by Valeris (Triangle), a premier strategy consulting firm thatdelivers high-impact solutions across the life sciences value chain, has announced the appointment ofErin Solano to Partner. Solano is a seasoned life sciences executive who possesses strong analytical and communication skillsresponsible for driving meaningful commercial success for her clients. She possesses diverse […]

Read More

March 6, 2026

IRA Part D Redesign – Market Impact & Unintended Consequences

The Inflation Reduction Act’s (IRA) Part D redesign provisions went into effect onJanuary 1, 2025, fundamentally restructuring cost-sharing corridors and upsetting themarketplace. By increasing plan and manufacturer liability, particularly in thecatastrophic phase, this legislation intended to lower the financial burden onbeneficiaries. When the IRA passed, the commonly held hypothesis in the marketplace was that Part […]

Read More

February 23, 2026

Rare Disease in 2026: What Investors Expect and How Companies Must Evolve

In 2026, rare disease investors are prioritizing more than promising science. From commercial readiness to clear revenue pathways, expectations are shifting — and companies must evolve to secure funding and long-term growth.

Read More

December 1, 2025

Forecasting Through an Uncertain Access Environment

Market access uncertainty is reshaping how life sciences companies forecast revenue and plan for launch. As pricing pressure, policy changes, and payer dynamics evolve, commercial teams must adopt more agile, data-driven forecasting strategies to stay competitive.

Read More

November 1, 2025

New Product Planning: Am I Doing It Right?

Planning a new product launch can be challenging. From assessing market needs to aligning cross-functional teams, companies must follow proven strategies to ensure a smooth, successful launch that meets commercial and compliance expectations.

Read More